Resources

Bloomberg recently highlighted RegASK’s insights on the growing challenges pharmaceutical companies face due to new U.S. tariffs. The art…

We’re thrilled to share that our CEO, Caroline Shleifer, has been quoted in ‘Labiotech’—One of Europe’s leading biotech ne…

We’re thrilled to share that our CEO, Caroline Shleifer, has been featured in Pharmaceutical Commerce! Read the article and find out how T…

🚀 Revolutionize Your Regulatory Intelligence at Regulatory Affairs Professionals Society (RAPS) 2025 with RegASK! 🚀 Attention regulato…

🌟 Revolutionizing Regulatory Intelligence: RegASK Takes Center Stage! 🚀 Prepare for a game-changing moment in life sciences compliance…

We’re proud to share that RegASK has been featured in Cosmetics Design USA! Insights from our 2025 State of Regulatory Affairs and Complia…

We are proud to announce that our 2025 State of Regulatory Affairs and Compliance Report has been featured in Corporate Compliance Insightsâ…

We’re excited to share that RegASK has been featured in The Wall Street Journal’s Risk and Compliance Newsletter, showcasing the insight…

We’re thrilled to share that in October 2024, RegASK hit a major milestone: over 3 million user actions. This achievement underscores how …

We’re thrilled to share that RegASK has been included in Gartner’s Market Guide for Regulatory Intelligence Solutions! This recognition …